To the best of our knowledge, for the first time, we demonstrated that obesity-related circulating exosomes can impair insulin signaling pathways and associated components, as well as increase intracellular TG content, and decrease the secretion of FGF21 in the hepatocytes. The gene discussed is INS; the disease is obesity disorder.